Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis
- PMID: 25344734
- PMCID: PMC4280258
- DOI: 10.1001/jama.2014.13959
Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis
Abstract
Importance: Plasma low-density lipoprotein cholesterol (LDL-C) has been associated with aortic stenosis in observational studies; however, randomized trials with cholesterol-lowering therapies in individuals with established valve disease have failed to demonstrate reduced disease progression.
Objective: To evaluate whether genetic data are consistent with an association between LDL-C, high-density lipoprotein cholesterol (HDL-C), or triglycerides (TG) and aortic valve disease.
Design, setting, and participants: Using a Mendelian randomization study design, we evaluated whether weighted genetic risk scores (GRSs), a measure of the genetic predisposition to elevations in plasma lipids, constructed using single-nucleotide polymorphisms identified in genome-wide association studies for plasma lipids, were associated with aortic valve disease. We included community-based cohorts participating in the CHARGE consortium (n = 6942), including the Framingham Heart Study (cohort inception to last follow-up: 1971-2013; n = 1295), Multi-Ethnic Study of Atherosclerosis (2000-2012; n = 2527), Age Gene/Environment Study-Reykjavik (2000-2012; n = 3120), and the Malmö Diet and Cancer Study (MDCS, 1991-2010; n = 28,461).
Main outcomes and measures: Aortic valve calcium quantified by computed tomography in CHARGE and incident aortic stenosis in the MDCS.
Results: The prevalence of aortic valve calcium across the 3 CHARGE cohorts was 32% (n = 2245). In the MDCS, over a median follow-up time of 16.1 years, aortic stenosis developed in 17 per 1000 participants (n = 473) and aortic valve replacement for aortic stenosis occurred in 7 per 1000 (n = 205). Plasma LDL-C, but not HDL-C or TG, was significantly associated with incident aortic stenosis (hazard ratio [HR] per mmol/L, 1.28; 95% CI, 1.04-1.57; P = .02; aortic stenosis incidence: 1.3% and 2.4% in lowest and highest LDL-C quartiles, respectively). The LDL-C GRS, but not HDL-C or TG GRS, was significantly associated with presence of aortic valve calcium in CHARGE (odds ratio [OR] per GRS increment, 1.38; 95% CI, 1.09-1.74; P = .007) and with incident aortic stenosis in MDCS (HR per GRS increment, 2.78; 95% CI, 1.22-6.37; P = .02; aortic stenosis incidence: 1.9% and 2.6% in lowest and highest GRS quartiles, respectively). In sensitivity analyses excluding variants weakly associated with HDL-C or TG, the LDL-C GRS remained associated with aortic valve calcium (P = .03) and aortic stenosis (P = .009). In instrumental variable analysis, LDL-C was associated with an increase in the risk of incident aortic stenosis (HR per mmol/L, 1.51; 95% CI, 1.07-2.14; P = .02).
Conclusions and relevance: Genetic predisposition to elevated LDL-C was associated with presence of aortic valve calcium and incidence of aortic stenosis, providing evidence supportive of a causal association between LDL-C and aortic valve disease. Whether earlier intervention to reduce LDL-C could prevent aortic valve disease merits further investigation.
Figures
Similar articles
-
Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study.Eur Heart J. 2020 Oct 21;41(40):3913-3920. doi: 10.1093/eurheartj/ehaa070. Eur Heart J. 2020. PMID: 32076698 Free PMC article.
-
Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol.Circ Cardiovasc Imaging. 2024 Jun;17(6):e016372. doi: 10.1161/CIRCIMAGING.123.016372. Epub 2024 Jun 18. Circ Cardiovasc Imaging. 2024. PMID: 38889215
-
Genetic Determinants of Lipids and Cardiovascular Disease Outcomes: A Wide-Angled Mendelian Randomization Investigation.Circ Genom Precis Med. 2019 Dec;12(12):e002711. doi: 10.1161/CIRCGEN.119.002711. Epub 2019 Nov 22. Circ Genom Precis Med. 2019. PMID: 31756303 Free PMC article.
-
Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis.JAMA Cardiol. 2018 Jan 1;3(1):26-33. doi: 10.1001/jamacardio.2017.4293. JAMA Cardiol. 2018. PMID: 29188294 Free PMC article. Review.
-
Molecular Linkage under the Bicuspid Aortic Valve with Dyslipidemia.Front Biosci (Landmark Ed). 2023 Feb 22;28(2):32. doi: 10.31083/j.fbl2802032. Front Biosci (Landmark Ed). 2023. PMID: 36866543 Review.
Cited by
-
Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells.BMC Med. 2024 Mar 14;22(1):122. doi: 10.1186/s12916-024-03342-x. BMC Med. 2024. PMID: 38486246 Free PMC article.
-
Models for calcific aortic valve disease in vivo and in vitro.Cell Regen. 2024 Mar 1;13(1):6. doi: 10.1186/s13619-024-00189-8. Cell Regen. 2024. PMID: 38424219 Free PMC article. Review.
-
Leveraging the transcriptome to further our understanding of GWAS findings: eQTLs associated with genes related to LDL and LDL subclasses, in a cohort of African Americans.Front Genet. 2024 Feb 7;15:1345541. doi: 10.3389/fgene.2024.1345541. eCollection 2024. Front Genet. 2024. PMID: 38384714 Free PMC article.
-
Remnant cholesterol and the risk of aortic valve calcium progression: insights from the MESA study.Cardiovasc Diabetol. 2024 Jan 9;23(1):20. doi: 10.1186/s12933-023-02081-2. Cardiovasc Diabetol. 2024. PMID: 38195550 Free PMC article.
-
Traditional and novel risk factors for incident aortic stenosis in community-dwelling older adults.Heart. 2023 Dec 15;110(1):57-64. doi: 10.1136/heartjnl-2023-322709. Heart. 2023. PMID: 37463733
References
-
- Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231–1243. - PubMed
-
- Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630–634. - PubMed
-
- Cowell SJ, Newby DE, Prescott RJ, et al. Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352(23):2389–2397. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- R01-HL-071258/HL/NHLBI NIH HHS/United States
- R01 HL071259/HL/NHLBI NIH HHS/United States
- R01 HL071252/HL/NHLBI NIH HHS/United States
- N01 HC025195/HC/NHLBI NIH HHS/United States
- N01-HC-95159/HC/NHLBI NIH HHS/United States
- N02HL64278/HL/NHLBI NIH HHS/United States
- T32 HL007208/HL/NHLBI NIH HHS/United States
- R01-HL-071259/HL/NHLBI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- KL2 TR002317/TR/NCATS NIH HHS/United States
- N01-HC-95161/HC/NHLBI NIH HHS/United States
- R01-HL-071051/HL/NHLBI NIH HHS/United States
- N01-HC-95166/HC/NHLBI NIH HHS/United States
- R01 HL071258/HL/NHLBI NIH HHS/United States
- R01 HL071739/HL/NHLBI NIH HHS/United States
- N01-HC-95162/HC/NHLBI NIH HHS/United States
- MOP-126033/CAPMC/ CIHR/Canada
- N01AG12100/AG/NIA NIH HHS/United States
- R01-HL-071252/HL/NHLBI NIH HHS/United States
- N01 AG012100/AG/NIA NIH HHS/United States
- R01 HL071251/HL/NHLBI NIH HHS/United States
- N01-HC-95163/HC/NHLBI NIH HHS/United States
- R01-HL-071250/HL/NHLBI NIH HHS/United States
- N01-HC-95168/HC/NHLBI NIH HHS/United States
- UL1 RR024156/RR/NCRR NIH HHS/United States
- N02 HL64278/HL/NHLBI NIH HHS/United States
- R01 HL071250/HL/NHLBI NIH HHS/United States
- N01 HC065226/HC/NHLBI NIH HHS/United States
- N01-HC-95165/HC/NHLBI NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- MOP-119380/CAPMC/ CIHR/Canada
- R01-HL-071251/HL/NHLBI NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- R01 HL071051/HL/NHLBI NIH HHS/United States
- N01-HC-95169/HC/NHLBI NIH HHS/United States
- N01-HC-95164/HC/NHLBI NIH HHS/United States
- N01HC95159/HL/NHLBI NIH HHS/United States
- R01-HL-071205/HL/NHLBI NIH HHS/United States
- N01 HC095169/HC/NHLBI NIH HHS/United States
- N01-HC-95160/HC/NHLBI NIH HHS/United States
- N01HC65226/HL/NHLBI NIH HHS/United States
- N01HC25195/HL/NHLBI NIH HHS/United States
- R01 HL071205/HL/NHLBI NIH HHS/United States
- N01 HC095159/HC/NHLBI NIH HHS/United States
- N01-HC-95167/HC/NHLBI NIH HHS/United States
- N01-HC-65226/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous